Skip to main content

Cookies on the NHS England website

We’ve put some small files called cookies on your device to make our site work.

We’d also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site.

Let us know if this is OK. We’ll use a cookie to save your choice. You canĀ read more about our cookies before you choose.

 

Your feedback matters and will make a difference. Help us understand your digital experience by taking our 10 minute survey. Your responses are completely anonymous. Start the survey.

  • Home
  • News
  • Publications
  • Statistics
  • Blogs
  • Events
  • Contact us
NHS England
  • About us
  • Our work
  • Commissioning
  • Get involved

Bendamustine for relapsed multiple myeloma (all ages)

Document first published:
9 July 2020
Page updated:
1 June 2021
Topic:
Commissioning, Medicine, Specialised commissioning
Publication type:
Policy or strategy

Document

Clinical commissioning policy proposition: Bendamustine for relapsed multiple myeloma (all ages)

Clinical commissioning policy proposition: Bendamustine for relapsed multiple myeloma (all ages)

  • PDF
  • 186 KB
  • 15 pages

Document

CPAG summary report: Bendamustine for relapsed multiple myeloma (all ages)

CPAG summary report: Bendamustine for relapsed multiple myeloma (all ages)

  • PDF
  • 58 KB
  • 5 pages

Document

Equality impact assessment: Bendamustine for relapsed multiple myeloma (all ages)

Equality impact assessment: Bendamustine for relapsed multiple myeloma (all ages)

  • PDF
  • 38 KB
  • 2 pages

Document

Impact assessment: Bendamustine for relapsed multiple myeloma (all ages)

Impact assessment: Bendamustine for relapsed multiple myeloma (all ages)

  • PDF
  • 128 KB
  • 18 pages

Document

Evidence review: Bendamustine for relapsed multiple myeloma (all ages)

Evidence review: Bendamustine for relapsed multiple myeloma (all ages)

  • PDF
  • 575 KB
  • 34 pages

Document

Consultation: Bendamustine for relapsed multiple myeloma (all ages)

Consultation: Bendamustine for relapsed multiple myeloma (all ages)

  • PDF
  • 48 KB
  • 3 pages
  • Terms and conditions
  • Privacy and cookies
  • Social media moderation
  • Website feedback
  • Accessibility statement
  • Open Government Licence v3.0
  • Sign up to our email bulletins
  • Follow us on X
  • Follow us on Facebook
  • Find us on Instagram
  • Visit us on LinkedIn
  • Watch videos on YouTube
NHS website